Syncom - Great results - Buy above 19. SL - 18Syncom a Penny _Pharma Stock has declared great set of results.
One can enter above 19/20 and gradually average up. for targets of 24/27 (if bull rally stustains).
With stop loss of 18.
Results
#Syncom
Rev at 165cr vs 78cr, Q3 at 132cr
PBT at 23cr vs 10cr, Q3 at 17cr
PAT at 18cr vs 8cr, Q3
0.50 INR
494.35 M INR
4.65 B INR
462.33 M
About SYNCOM FORMU (I) LTD
Sector
Industry
CEO
Vijay Shankarlal Bankda
Website
Headquarters
Indore
Founded
1988
ISIN
INE312C01025
FIGI
BBG000D7VG18
Syncom Formulations (India) Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company operates through the following segments: Pharmaceutical Drugs and Formulations, Trading of Commodities, and Renting of Property. The company was founded by Kedarmal Shankarlal Bankda, Ajay Kumar Bankda, and Vijay Shankarlal Bankda on June 21, 1988 and is headquartered in Indore, India.
Syncom Formulations (India) LtdDate 12.05.2025
Syncom Formulations
Timeframe : Day Chart
Remarks ::
Wait for the price to breakout from ichimoku cloud & 200 exponential moving average
Potential upside from breakout is 20%
About ::
Established in the year 1995, Syncom Formulations is a global pharmaceutical company that ma
SYNCOMF FOR 3-6 MONTHSFor 3-6 Months
Fundamentally,
> Revenue Growth over 60% Quarterly
> Net Income Growth over 70% Quarterly
> EPS over 40% Yearly
Technically,
> Trading at the point of historically tested demand zone.
> Rising relative strength.
> Market Profile also suggesting an upmove.
> Current levels suggests
Syncom Formula - Best Above 14. Syncom Formula - Sector tailwinds and push for generics the stock may rise from here
Please note this is still considered to penny stock with decent fundamentals. However don't go overboard and use only 1/2% of your capital. This stock will definitely test your patience.
Use Buy on dip strategy.
BUY TODAY SELL TOMORROW for 5% DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed t
#SYNCOMF Weekly Chart AnalysisHello, fellow traders and investors! 📊 Let's delve into a thorough analysis of SYNCOMF's weekly chart, unearthing a compelling blend of a demand zone touch, evident RSI support, and the unique considerations of dealing with a micro-cap company. 📈💼
📈 Technical Insights:
✨ Demand Zone Influence: SYNC
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of SYNCOMF is 19.47 INR — it has decreased by −1.17% in the past 24 hours. Watch SYNCOM FORMULATIONS (INDIA) LT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SYNCOM FORMULATIONS (INDIA) LT stocks are traded under the ticker SYNCOMF.
SYNCOMF stock has risen by 14.80% compared to the previous week, the month change is a 9.08% rise, over the last year SYNCOM FORMULATIONS (INDIA) LT has showed a 47.50% increase.
SYNCOMF reached its all-time high on Sep 10, 2024 with the price of 27.94 INR, and its all-time low was 0.15 INR and was reached on Aug 13, 2013. View more price dynamics on SYNCOMF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SYNCOMF stock is 3.81% volatile and has beta coefficient of 1.57. Track SYNCOM FORMULATIONS (INDIA) LT stock price on the chart and check out the list of the most volatile stocks — is SYNCOM FORMULATIONS (INDIA) LT there?
Today SYNCOM FORMULATIONS (INDIA) LT has the market capitalization of 18.30 B, it has increased by 4.37% over the last week.
Yes, you can track SYNCOM FORMULATIONS (INDIA) LT financials in yearly and quarterly reports right on TradingView.
SYNCOMF net income for the last quarter is 176.94 M INR, while the quarter before that showed 130.02 M INR of net income which accounts for 36.09% change. Track more SYNCOM FORMULATIONS (INDIA) LT financial stats to get the full picture.
SYNCOM FORMULATIONS (INDIA) LT dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNCOM FORMULATIONS (INDIA) LT EBITDA is 550.98 M INR, and current EBITDA margin is 11.64%. See more stats in SYNCOM FORMULATIONS (INDIA) LT financial statements.
Like other stocks, SYNCOMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNCOM FORMULATIONS (INDIA) LT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNCOM FORMULATIONS (INDIA) LT technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNCOM FORMULATIONS (INDIA) LT stock shows the buy signal. See more of SYNCOM FORMULATIONS (INDIA) LT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.